The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 No. 775

SCHEDULE 8 U.K. Consequential provision

PART 2 U.K. Amendment of secondary legislation

Amendment of the Genetically Modified Organisms (Contained Use) Regulations (Northern Ireland) 2015 U.K.

14.  In regulation 3(2)(b) of the Genetically Modified Organisms (Contained Use) Regulations (Northern Ireland) 2015 (application) M1 , at the end insert—

“; or

(iv) a medicinal product for human use marketed in accordance with the Human Medicines Regulations 2012;”.

Commencement Information

I1 Sch. 8 para. 14 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

Marginal Citations

M1 S.R. 2015 No. 339.